Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)

19006 Background: We conducted a randomized monocentric study to compare the treatment response of two chemotherapy doublets GP versus EP. Time to disease progression, survival time and toxicity we...